652 related articles for article (PubMed ID: 33204330)
21. N6-methyladenosine modification of circCUX1 confers radioresistance of hypopharyngeal squamous cell carcinoma through caspase1 pathway.
Wu P; Fang X; Liu Y; Tang Y; Wang W; Li X; Fan Y
Cell Death Dis; 2021 Mar; 12(4):298. PubMed ID: 33741902
[TBL] [Abstract][Full Text] [Related]
22. YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation.
Huang X; Zhu L; Wang L; Huang W; Tan L; Liu H; Huo J; Su T; Zhang M; Kuang M; Li X; Dai Z; Xu L
J Gastroenterol Hepatol; 2022 Jun; 37(6):1156-1168. PubMed ID: 35233828
[TBL] [Abstract][Full Text] [Related]
23. LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.
Ban Y; Tan P; Cai J; Li J; Hu M; Zhou Y; Mei Y; Tan Y; Li X; Zeng Z; Xiong W; Li G; Li X; Yi M; Xiang B
Mol Oncol; 2020 Jun; 14(6):1282-1296. PubMed ID: 32216017
[TBL] [Abstract][Full Text] [Related]
24. RNA m
Lin X; Chai G; Wu Y; Li J; Chen F; Liu J; Luo G; Tauler J; Du J; Lin S; He C; Wang H
Nat Commun; 2019 May; 10(1):2065. PubMed ID: 31061416
[TBL] [Abstract][Full Text] [Related]
25. YTHDF1 Aggravates the Progression of Cervical Cancer Through m
Wang H; Luo Q; Kang J; Wei Q; Yang Y; Yang D; Liu X; Liu T; Yi P
Front Oncol; 2021; 11():650383. PubMed ID: 33816306
[TBL] [Abstract][Full Text] [Related]
26. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
27. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
[TBL] [Abstract][Full Text] [Related]
28. Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma.
Tsai YT; Chen WC; Chien CY; Hsu CM; Lee YC; Tsai MS; Lin MH; Lai CH; Chang KP
World J Surg Oncol; 2020 May; 18(1):82. PubMed ID: 32357934
[TBL] [Abstract][Full Text] [Related]
29. m
Jia R; Chai P; Wang S; Sun B; Xu Y; Yang Y; Ge S; Jia R; Yang YG; Fan X
Mol Cancer; 2019 Nov; 18(1):161. PubMed ID: 31722709
[TBL] [Abstract][Full Text] [Related]
30. Development of a complete human anti-human transferrin receptor C antibody as a novel marker of oral dysplasia and oral cancer.
Nagai K; Nakahata S; Shimosaki S; Tamura T; Kondo Y; Baba T; Taki T; Taniwaki M; Kurosawa G; Sudo Y; Okada S; Sakoda S; Morishita K
Cancer Med; 2014 Aug; 3(4):1085-99. PubMed ID: 24890018
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis.
Kindrat I; Tryndyak V; de Conti A; Shpyleva S; Mudalige TK; Kobets T; Erstenyuk AM; Beland FA; Pogribny IP
Oncotarget; 2016 Jan; 7(2):1276-87. PubMed ID: 26657500
[TBL] [Abstract][Full Text] [Related]
32. N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.
Zhang X; Su T; Wu Y; Cai Y; Wang L; Liang C; Zhou L; Wang S; Li XX; Peng S; Kuang M; Yu J; Xu L
Cancer Res; 2024 Mar; 84(6):827-840. PubMed ID: 38241695
[TBL] [Abstract][Full Text] [Related]
33. EGR2-mediated regulation of m
Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
[TBL] [Abstract][Full Text] [Related]
34. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
35. Aberrantly expressed genes and miRNAs in human hypopharyngeal squamous cell carcinoma based on RNA‑sequencing analysis.
Li H; Wang F; Fei Y; Lei Y; Lu F; Guo P; Li W; Xun X
Oncol Rep; 2018 Aug; 40(2):647-658. PubMed ID: 29916534
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of m
Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumour immunity controlled through mRNA m
Han D; Liu J; Chen C; Dong L; Liu Y; Chang R; Huang X; Liu Y; Wang J; Dougherty U; Bissonnette MB; Shen B; Weichselbaum RR; Xu MM; He C
Nature; 2019 Feb; 566(7743):270-274. PubMed ID: 30728504
[TBL] [Abstract][Full Text] [Related]
38. M6A reader YTHDF1 promotes malignant progression of laryngeal squamous carcinoma through activating the EMT pathway by EIF4A3.
Guo H; Han Q; Guan X; Li Z; Wang Y; He L; Guo Y; Zhao L; Xue X; Liu H; Zhang C
Cell Signal; 2024 Feb; 114():111002. PubMed ID: 38048860
[TBL] [Abstract][Full Text] [Related]
39. Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway.
Wang F; Xu WQ; Zhang WQ; Xu RC; Sun JL; Zhang GC; Liu ZY; Qi ZR; Dong L; Weng SQ; Shen XZ; Liu TT; Fang Y; Zhu JM
Hepatol Int; 2024 Apr; 18(2):636-650. PubMed ID: 37982952
[TBL] [Abstract][Full Text] [Related]
40. Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer.
Mints M; Landin D; Näsman A; Mirzaie L; Ursu RG; Zupancic M; Marklund L; Dalianis T; Munck-Wikland E; Ramqvist T
Sci Rep; 2021 Jan; 11(1):1782. PubMed ID: 33469045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
